Raymond James & Associates Has $257,000 Stock Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Raymond James & Associates lessened its stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 50.8% in the 4th quarter, Holdings Channel reports. The institutional investor owned 6,183 shares of the company’s stock after selling 6,393 shares during the quarter. Raymond James & Associates’ holdings in SPDR S&P Pharmaceuticals ETF were worth $257,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in XPH. LPL Financial LLC lifted its position in shares of SPDR S&P Pharmaceuticals ETF by 26.4% in the third quarter. LPL Financial LLC now owns 124,782 shares of the company’s stock worth $4,960,000 after purchasing an additional 26,031 shares in the last quarter. Envestnet Portfolio Solutions Inc. acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth about $1,938,000. Janney Montgomery Scott LLC grew its holdings in shares of SPDR S&P Pharmaceuticals ETF by 9.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 5,835 shares of the company’s stock valued at $232,000 after acquiring an additional 500 shares in the last quarter. Kingsview Wealth Management LLC bought a new stake in SPDR S&P Pharmaceuticals ETF during the third quarter worth about $696,000. Finally, Ieq Capital LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the third quarter valued at approximately $550,000.

SPDR S&P Pharmaceuticals ETF Stock Up 1.2 %

Shares of SPDR S&P Pharmaceuticals ETF stock opened at $39.98 on Tuesday. SPDR S&P Pharmaceuticals ETF has a 12-month low of $34.67 and a 12-month high of $45.62. The business’s 50 day moving average is $42.28 and its 200-day moving average is $40.61. The stock has a market cap of $195.90 million, a P/E ratio of 14.45 and a beta of 0.87.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.